Janney Montgomery Scott’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-7,220
Closed -$246K – 2366
2021
Q4
$246K Sell
7,220
-8,525
-54% -$334K ﹤0.01% 2120
2021
Q3
$760K Sell
15,745
-41,360
-72% -$1.91M ﹤0.01% 1424
2021
Q2
$2.58M Buy
57,105
+51,114
+853% +$2.26M 0.01% 833
2021
Q1
$289K Buy
5,991
+1,164
+24% +$60.6K ﹤0.01% 1873
2020
Q4
$260K Buy
+4,827
New +$218K ﹤0.01% 1970
2017
Q3
– Sell
-10,500
Closed -$94K – 1851
2017
Q2
$94K Buy
+10,500
New +$83.3K ﹤0.01% 1701

Other funds holding NEO

Janney Montgomery Scott's NEO Position: Q1 2022 in Review

Janney Montgomery Scott sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 7,220 shares — an estimated $246K sold.

Janney Montgomery Scott first reported a position in NEO in Q2 2017 and held it in 6 quarters. The position peaked at $2.58M in Q2 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Janney Montgomery Scott reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 7,220 NeoGenomics shares in Q1 2022, an estimated $246K.
  • Janney Montgomery Scott first reported a position in NeoGenomics in Q2 2017 and held it in 6 quarters.
  • Janney Montgomery Scott's NeoGenomics position peaked at $2.58M in Q2 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Janney Montgomery Scott's 13F filing for Q1 2022, filed 4 May 2022.